Top Markets
Coin of the day
Renalytix Plc Renalytix Plc

Renalytix Plc

RNLX
Κατάταξη σε μετοχές #33998
Renalytix Plc, established in New York in 2018 and known as Renalytix AI plc... Renalytix Plc, established in New York in 2018 and known as Renalytix AI plc until its name change in June 2021, focuses on creating artificial intelligence-driven in vitro diagnostic tools for kidney ailments. Its primary product, KidneyIntelX, is an advanced diagnostic system that utilizes an AI-powered algorithm. This algorithm integrates multiple data sources, including scientifically validated blood markers, genetic predispositions, and individual patient information from electronic health records, to produce a distinct risk score for kidney disease. The company's technology is applied in various areas: identifying and predicting the course of kidney disease, informing clinical treatment, selecting patients for pharmaceutical trials, and discovering new therapeutic targets. Renalytix has formed several strategic collaborations, such as licensing agreements with Mount Sinai Health System for AI-assisted kidney disease diagnosis, with Joslin Diabetes Center, Inc. for developing biomarker-based kidney disease prediction products, and with Kantaro Biosciences LLC for laboratory tests to detect SARS-CoV-2 antibodies. Furthermore, it has partnered with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to introduce an innovative clinical care model aimed at improving kidney health outcomes and preventing disease advancement and failure in vulnerable populations.
Τιμή μετοχής
$0.1502
Τελευταίος συγχρονισμός: 2024-11-04
Κεφαλαιοποίηση
$6.43M
Αλλαγή (1 ημέρα)
-5.45%
Αλλαγή (1 έτος)
0.00%
Χώρα
US
Εμπόριο Renalytix Plc (RNLX)

Κατηγορία

EPS για Renalytix Plc (RNLX)
EPS στις September 2024 TTM: $-0.52
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή της μετοχής της Renalytix Plc, το τρέχον EPS της εταιρείας (TTM) είναι $-0.52. Στο τέλος του 2023, η εταιρεία είχε EPS $-1.10, μείωση σε σύγκριση με το EPS του 2022 που ήταν $-1.24.
Ιστορικό EPS της Renalytix Plc από 2018 έως 2026
EPS στο τέλος κάθε έτους
Έτος EPS Αλλαγή
2026 (TTM) $-0.52 -16.13%
2024 $-0.62 -43.64%
2023 $-1.10 -11.29%
2022 $-1.24 26.53%
2021 $-0.98 188.24%
2020 $-0.34 -82.83%
2019 $-1.98 3,200.00%
2018 $-0.06 0.00%
EPS για παρόμοιες εταιρείες ή ανταγωνιστές
Εταιρεία EPS Διαφορά EPS Χώρα
$3.48 -769.23%
US
$1.50 -388.62%
AU
$1.43 -375.00%
US
$-1.43 175.00%
US
- -
US